New proprietary research from Oriflame redefines beauty as a powerful driver of wellbeing STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Global…
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller…
October 05, 2025 09:00 ET | Source: Spyre Therapeutics, Inc. WALTHAM, Mass., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics,…
HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by The Hong Kong University of Science and Technology…
19th year of survey reveals cybersecurity remains top concern as workforce-related risks fall on global risk agenda DUBLIN, Oct. 1,…
New findings reveal critical microbial drivers, ethnic variations, and new pathways for personalized scalp care NEW YORK, Sept. 29, 2025…
As part of New York Climate Week, LanzaJet's CEO addressed the President of the Republic of Kazakhstan and met with…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…